Prevalence of antibodies to four herpesviruses among adults with glioma and controls.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 11447050)

Published in Am J Epidemiol on July 15, 2001

Authors

M Wrensch1, A Weinberg, J Wiencke, R Miike, G Barger, K Kelsey

Author Affiliations

1: Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA 94143-1215, USA. wrensch@itsa.ucsf.edu

Articles citing this

Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol (2008) 1.94

Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine (2012) 1.88

The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study. Br J Cancer (2004) 1.13

Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes Control (2011) 0.90

The roles of viruses in brain tumor initiation and oncomodulation. J Neurooncol (2011) 0.88

Antihistamine use and immunoglobulin E levels in glioma risk and prognosis. Cancer Epidemiol (2013) 0.87

Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens. J Virol (2003) 0.86

The association between birth order, sibship size and glioma development in adulthood. Int J Cancer (2010) 0.84

Chronic viral infection and primary central nervous system malignancy. J Neuroimmune Pharmacol (2010) 0.84

History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Cancer Med (2016) 0.83

Season of birth and risk for adult onset glioma. Int J Environ Res Public Health (2010) 0.83

Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk. Int J Cancer (2013) 0.80

Cytotoxicity of glioblastoma cells mediated ex vivo by varicella-zoster virus-specific T cells. J Neurovirol (2011) 0.78

Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis. Cancer Med (2013) 0.78

Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia Aging Study. J Neurooncol (2012) 0.77

Herpes Simplex Virus (HSV-1) Encephalitis Mimicking Glioblastoma: Case Report and Review of the Literature. J Clin Med (2014) 0.75

Articles by these authors

Chemical structure and sympathomimetic action of amines. J Physiol (1910) 32.80

beta-Iminazolylethylamine a depressor constituent of intestinal mucosa. J Physiol (1911) 17.25

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06

Chemistry of Thyroxine: Constitution and Synthesis of Thyroxine. Biochem J (1927) 17.01

Isolation of the pressor principles of putrid meat. J Physiol (1909) 15.10

Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun (1995) 4.33

Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun (2000) 2.55

Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25

Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol (1991) 2.15

Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst (2001) 2.13

A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res (1996) 2.03

The future of scattered trees in agricultural landscapes. Conserv Biol (2008) 1.92

Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun (1998) 1.86

A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis (1997) 1.84

Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin Diagn Lab Immunol (2000) 1.67

Tear gas--harassing agent or toxic chemical weapon? JAMA (1989) 1.66

Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol (1997) 1.63

Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA) Cancer Causes Control (1997) 1.63

Effects of a medical team coordinator on length of hospital stay. CMAJ (1992) 1.61

Effect of prenatal dexamethasone on rat renal development. Kidney Int (2001) 1.58

Localized antimicrobial peptide expression in human gingiva. J Periodontal Res (2001) 1.58

Studies on EB virus of Burkitt's lymphoblasts. Virology (1969) 1.57

Continuing medical education: does it address prevention? J Community Health (1982) 1.53

Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol (1997) 1.52

Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res (2005) 1.50

CSF and MRI findings in patients with acute herpes zoster. Neurology (1998) 1.49

Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol (1992) 1.48

Giant melanoma of the inner thigh: a homeopathic life-threatening negligence. Ann Plast Surg (1991) 1.48

Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res (2000) 1.46

Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat (1990) 1.45

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol (2000) 1.45

Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev (2000) 1.43

Two decades of abdominal aortic aneurysm repair: have we made any progress? J Vasc Surg (2000) 1.42

Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol (1995) 1.42

The inframammary midline triangle in reduction mammaplasty: the renewal of an old idea. Plast Reconstr Surg (1994) 1.40

Fitness for duty evaluations in hazardous materials firefighters. J Occup Environ Med (1998) 1.38

NOTE ON A SUPPOSED SOLUBLE TOXIN, PRODUCED IN ARTIFICIAL CULTURE BY THE BACILLUS OF MALIGNANT OEDEMA. Br Med J (1915) 1.38

A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg (1997) 1.37

Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob Agents Chemother (2001) 1.36

Immunization of HIV-infected children with varicella vaccine. J Pediatr (2001) 1.35

Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect (2000) 1.35

Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer (2000) 1.33

Interbacterial binding among strains of pathogenic and commensal oral bacterial species. Oral Microbiol Immunol (1996) 1.33

Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun (1994) 1.30

Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.29

Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev (1996) 1.28

Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis (2003) 1.27

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother (2000) 1.27

A proposal for examining and reporting stepwise regressions. Stat Med (1991) 1.26

Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob Agents Chemother (1999) 1.20

A semiquantitative dietary history questionnaire for Chinese Americans. Ann Epidemiol (1994) 1.17

A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J Clin Invest (1993) 1.17

Environmental risk factors for primary malignant brain tumors: a review. J Neurooncol (1993) 1.15

Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer (1987) 1.14

Inhibition of superoxide production in human polymorphonuclear leukocytes by oral treponemal factors. Infect Immun (1988) 1.13

Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infection. J Immunol (1986) 1.13

Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns. Burns (1998) 1.11

Late complications of the modified Indiana pouch. J Urol (1994) 1.10

The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect (2001) 1.08

Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant (2007) 1.07

[The mallet finger in children and adolescents]. Handchir Mikrochir Plast Chir (2008) 1.05

Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol (2000) 1.05

[Pelvic fractures: epidemiology, therapy and long-term outcome. Overview of the multicenter study of the Pelvis Study Group]. Unfallchirurg (1996) 1.05

delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med (1997) 1.05

Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res (2001) 1.04

The varicella-autoantibody syndrome. Pediatr Res (2001) 1.04

Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am J Surg (1997) 1.03

Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis (2001) 1.03

Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. Antimicrob Agents Chemother (1998) 1.03

Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst (1987) 1.02

Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01

Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates. J Clin Microbiol (1998) 1.00

Mobile rRNA methylase genes coding for erythromycin resistance in Actinobacillus actinomycetemcomitans. J Antimicrob Chemother (1996) 1.00

Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr (1996) 0.99

Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates. J Perinatol (2011) 0.99

Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes. Neurosurg Focus (2000) 0.98

Genetics of primary brain tumors: a review. J Neurooncol (1994) 0.98

Facial wrinkling in men and women, by smoking status. Am J Public Health (1995) 0.97

Expression of the antimicrobial peptide, human beta-defensin 1, in duct cells of minor salivary glands and detection in saliva. J Dent Res (2000) 0.97

Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs. J Virol (1987) 0.97

Are prior head injuries or diagnostic X-rays associated with glioma in adults? The effects of control selection bias. Neuroepidemiology (2000) 0.97

Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev (2001) 0.97

Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol (1997) 0.96

Surface tension: floater clustering in a standing wave. Nature (2005) 0.96

Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol Immunol (2003) 0.96

Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide. Transpl Infect Dis (2006) 0.95

Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg (1999) 0.95

Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant (1998) 0.94

Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient. Burns (1991) 0.93